What is the present valuation and projected CAGR of the smart pills market?
The smart pills market size has grown rapidly in recent years. It will grow from $5.39 billion in 2024 to $5.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to medication adherence, chronic disease management, clinical trials and research, aging population.
The smart pills market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to remote patient monitoring, regulatory and quality standards, clinical trials and research, digital health integration. Major trends in the forecast period include wireless health monitoring, diagnostic and imaging capsules, data analytics and artificial intelligence, smart pill sensors, miniaturization and biocompatibility.
Get Your Free Sample of The Global Smart Pills Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2846&type=smp
What key drivers have fueled the smart pills market’s development over the years?
The growing preference for non-invasive procedures is driving the smart pills market. The non-invasive procedures are diagnostic and treatment procedures that do not require an incision on the body or removal of tissues for the treatment or diagnosis. Smart pill is a wireless, ingestible capsule that can be easily swallowed and has a wide range of applications in capsule endoscopy, drug delivery, and patient monitoring. For instance, smart pills have key applications in diagnostic imaging such as capsule endoscopy. The capsule endoscopy is a diagnostic procedure in which a smart pill (capsule enclosed micro-camera) is swallowed and images of the esophagus, stomach, and small intestine can be taken as the device pass through your gastrointestinal (GI) tract. Smart pills have revolutionized the diagnosis of gastrointestinal disorders and could replace conventional diagnostic techniques such as endoscopy. Therefore, non-invasive procedures are driving the smart pills market during the period.
What is the segmentation for the smart pills market?
The smart pills market covered in this report is segmented –
1) By Target Area: Esophagus, Stomach, Small Intestine, Large Intestine
2) By Disease Indication: Esophageal Diseases, Colon Diseases, Small bowel Diseases, And Other Disease Indications
3) By Application: Capsule Endoscopy, Patient Monitoring, Drug Delivery
4) By End User: Hospital, Diagnostic Center, Research Institute
Subsegments:
1) By Esophagus: Diagnostic Pills For Esophageal Disorders, Pills For Monitoring Esophageal Motility
2) By Stomach: Gastric Emptying Monitoring Pills, Diagnostic Pills For Gastric Disorders
3) By Small Intestine: Pills For Absorption Studies, Diagnostic Pills For Small Bowel Diseases
4) By Large Intestine: Colonoscopy Alternative Pills, Pills For Detecting Colorectal Disorders
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report
Who are the most influential companies in the smart pills market?
Major companies operating in the smart pills market include Medtronic plc, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.
Which market trends are set to define the future of the smart pills market?
Extensive research and development are being carried out on the use of miniature chips such as Addressable Transmitters Operated as Magnetic Spins (ATOMS) which can be used as smart pills. ATOMS are silicon chip devices that use the principle of magnetic resonance imaging (MRI) to determine the location of atoms in a patient’s body using magnetic fields. ATOMS can be used in ingestible smart pills to diagnose and treat diseases from within the body. The devices can be used to monitor a patient’s gastrointestinal tract, blood, or brain. They also could measure factors that indicate the health of a patient such as pH, temperature, pressure, and sugar concentrations, and relay that information to doctors. The devices could even be instructed to release drugs. For instance, scientists at Caltech (California Institute of Technology) have developed a miniature medical chip that can be used as a smart pill.
How do regional factors impact the smart pills market, and which region is the largest contributor?
North America was the largest region in the smart pills market in 2023. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Smart Pills Market Report 2025 Offer?
The smart pills market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Smart pills are used to deliver medication and are equipped with electronic sensors that emit signals to be captured by patches or smartphones when they are swallowed. These pills ensure drug regimen compliance and help track medication adherence of patients.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2846
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
